Repligen Corp. (RGEN)
172.82
+2.80
(+1.65%)
USD |
NASDAQ |
Sep 02, 16:00
172.82
0.00 (0.00%)
After-Hours: 18:50
Repligen Research and Development Expense (TTM) : 55.23M for June 30, 2026
Research and Development Expense (TTM) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Research and Development Expense (TTM) Data
| Date | Value |
|---|---|
| June 30, 2026 | 55.23M |
| March 31, 2026 | 54.79M |
| December 31, 2025 | 52.44M |
| September 30, 2025 | 51.77M |
| June 30, 2025 | 47.31M |
| March 31, 2025 | 43.63M |
| December 31, 2024 | 42.59M |
| September 30, 2024 | 41.28M |
| June 30, 2024 | 42.11M |
| March 31, 2024 | 41.52M |
| December 31, 2023 | 42.61M |
| September 30, 2023 | 43.52M |
| June 30, 2023 | 43.16M |
| March 31, 2023 | 43.69M |
| December 31, 2022 | 43.37M |
| September 30, 2022 | 40.94M |
| June 30, 2022 | 39.91M |
| March 31, 2022 | 38.07M |
| December 31, 2021 | 33.84M |
| September 30, 2021 | 31.82M |
| June 30, 2021 | 27.09M |
| March 31, 2021 | 23.04M |
| December 31, 2020 | 20.13M |
| September 30, 2020 | 18.63M |
| June 30, 2020 | 19.64M |
| Date | Value |
|---|---|
| March 31, 2020 | 20.53M |
| December 31, 2019 | 19.45M |
| September 30, 2019 | 17.38M |
| June 30, 2019 | 15.55M |
| March 31, 2019 | 16.10M |
| December 31, 2018 | 15.77M |
| September 30, 2018 | 15.74M |
| June 30, 2018 | 14.14M |
| March 31, 2018 | 10.22M |
| December 31, 2017 | 8.671M |
| September 30, 2017 | 7.643M |
| June 30, 2017 | 7.528M |
| March 31, 2017 | 7.558M |
| December 31, 2016 | 7.355M |
| September 30, 2016 | 6.746M |
| June 30, 2016 | 6.35M |
| March 31, 2016 | 5.712M |
| December 31, 2015 | 5.740M |
| September 30, 2015 | 5.637M |
| June 30, 2015 | 5.797M |
| March 31, 2015 | 5.976M |
| December 31, 2014 | 5.609M |
| September 30, 2014 | 5.702M |
| June 30, 2014 | 5.482M |
| March 31, 2014 | 6.358M |
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (TTM) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (TTM) Benchmarks
| BioLife Solutions, Inc. | 8.25M |
| Danaher Corp. | 1.615B |
| Liquidia Corp. | 54.95M |
| Harmony Biosciences Holdings, Inc. | 220.87M |
| Agilent Technologies, Inc. | 480.00M |